Substance / Medication

Hydroxypropyl cellulose

Overview

Active Ingredient
hydroxypropylcellulose
RxNorm CUI
27291

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

4 trials linked to this intervention

4
Total Trials
0
Recruiting
3
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Improved signs, symptoms, and quality of life associated with dry eye syndrome: hydroxypropyl cellulose ophthalmic insert patient registry.
Koffler Bruce H, McDonald Marguerite, Nelinson Donald S et al. · Eye Contact Lens · 2010
PMID: 20351555Observational
Correlating patient-reported response to hydroxypropyl cellulose ophthalmic insert (LACRISERT®) therapy with clinical outcomes: tools for predicting response.
McDonald Marguerite, D'Aversa Gerard, Perry Henry D et al. · Curr Eye Res · 2010
PMID: 20858108Observational
Hydroxypropyl cellulose ophthalmic inserts (lacrisert) reduce the signs and symptoms of dry eye syndrome and improve patient quality of life.
McDonald Marguerite, D'Aversa Gerard, Perry Henry D et al. · Trans Am Ophthalmol Soc · 2009
PMID: 20126497ObservationalFull text (PMC)
Effect of hydroxypropyl cellulose (HPC) on dissolution rate of hydrochlorothiazide tablets.
Desai D, Rinaldi F, Kothari S et al. · Int J Pharm · 2006
PMID: 16321490Observational
In vitro evaluation of a hydroxypropyl cellulose gel system for transdermal delivery of timolol.
Stamatialis D F, Rolevink H H M, Gironès M et al. · Curr Drug Deliv · 2004
PMID: 16305393Observational
Hydroxypropyl cellulose-induced fixed drug eruption as an adverse effect of generic drugs.
Morishima Ryo, Bokuda Kota · Contact Dermatitis · 2021
PMID: 33460455Case Report

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Hydroxypropyl cellulose (substance)
SNOMED CT
386927006
UMLS CUI
C4281713
RxNorm CUI
27291

Clinical Data

This intervention maps to 1 entities in the Healos knowledge graph.

1
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
4
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.